okredo logo
none title certification

UAB "Cembalta" Finance - revenue, profit

eye icon
More information

EBITDA margin (%)

unlock data icon

Register and

explore Okredo data
More information

EBIT margin (%)

unlock data icon

Register and

explore Okredo data

EBITDA margin (%)

Login to see the data

EBIT margin (%)

Login to see the data

Financial statetment report

Price: €9.90
Premium users: 1.00 credit
Indicator
Turnover (€)
Sales per employee (€)info
Profit before tax (€)
Net Profit (€)
Profit per employee (€)info
Working capital requirementinfo
Debt-to-equity ratioinfo
Total profitability (%)info
Net profitability (%)info
Equity (€)
Amounts Payable And Liabilities (€)
Non-current Assets (€)
CurrentAssets (€)
EBITDA margin (%)info
EBITDA (€)info
EBIT margin (%)info
EBIT (€)info
2021
225,800
112,900
58,134
58,134
29,067
0.52
3.88
34.74
25.75
176,838
685,494
60,445
801,803
2022
12,380
6,221
34,293
32,828
16,496
16.87
3.26
16.72
265.17
209,666
684,365
811
893,220
2023
126,102
126,102
88,018
83,617
83,617
2.33
2.55
63.36
66.31
293,283
747,100
1
1,040,382
unlock data icon

Register and

explore Okredo data
2023
126,102
126,102
88,018
83,617
83,617
2.33
2.55
63.36
66.31
293,283
747,100
1
1,040,382
unlock data icon

Register and

explore Okredo data

2023

Turnover (€)

126,102 €Ascended919 % *

Sales per employee (€)

126,102 €Ascended1,927 % *

Profit before tax (€)

88,018 €Ascended157 % *

Net Profit (€)

83,617 €Ascended155 % *

Profit per employee (€)

83,617 €Ascended407 % *

Working capital requirement

2.33 Descended-86.19 % *

Debt-to-equity ratio

2.55 Descended-21.78 % *

Total profitability (%)

63.36 %Ascended278.95 % *

Net profitability (%)

66.31 %Descended-74.99 % *

Equity (€)

293,283 €Ascended40 % *

Amounts Payable And Liabilities (€)

747,100 €Ascended9 % *

Non-current Assets (€)

1 €Descended-100 % *

CurrentAssets (€)

1,040,382 €Ascended16 % *

*over the last year starting selected period